Task E13: Development of Interventional Agents for Infectious Diseases
Task E13: Development of Interventional Agents for Infectious Diseases
任务E13：传染病介入制剂的开发
批准号：
10933759
负责人：
ANTHONY GALLAGHER
金额：
$3.4万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
项目状态：
已结题
起止时间：
2023-09-11 至 2024-09-11
关键词：
AreaBiologicalBiological AssayChemistryCommunicable DiseasesContractsDevelopmentDevelopment PlansDrug KineticsEvaluationIn VitroInterventional Agent DevelopmentLeadNational Institute of Allergy and Infectious DiseasePropertySafetyServicesSupport ContractsTherapeuticToxicologyToxinin vivolead optimizationmanufacturepathogenpre-clinicalproduct developmentprogramsscreeningtherapeutic development
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task E13: Development of Interventional Agents for Infectious Diseases
-
批准号：10933756
-
项目类别：
-
资助金额：$15.43万
-
财政年份：2023
-
负责人：ANTHONY GALLAGHER
-
依托单位：--
Task E13: Development of Interventional Agents for Antibiotic Resistance Bacteria
-
批准号：10933758
-
项目类别：
-
资助金额：$15.43万
-
财政年份：2023
-
负责人：ANTHONY GALLAGHER
-
依托单位：--
海外基金
